Search results
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 10 hours ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 7 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 10 hours agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 21 hours agoRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 6 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company ...
AstraZeneca's Covid-19 vaccine linked to fatal blood clotting disorder?
MSN News· 10 hours agoThe PF4 antibodies in the classical adenoviral vector VITT and the adenovirus infection-associated...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 17 hours agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a ...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via Yahoo News· 19 hours agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
AstraZeneca's COVID prevention drug meets primary goals in late-stage study
Reuters· 18 hours agoAstraZeneca's investigational COVID-19 prevention therapy met its primary goals in a late-stage...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 14 hours agoWhile AstraZeneca’s globally used COVID-19 vaccine is leaving the scene, the British Big Pharma is...